CALL FOR APPLICATIONS FOR THE NATA 2025-2028 BOARD OF DIRECTORS
NATA is seeking dedicated leaders to help guide the Society into the future.
The NATA Board of Directors comprises a diverse group of professionals from different medical background, united by a shared commitment to ensuring that NATA remains internationally recognized as the leading society in Patient Blood Management (PBM), Haemostasis, and Thrombosis. The Board is responsible for upholding high standards in education, collaboration, and professional development for NATA members and the broader community.
The 2025-2028 Board of Directors will be presided over by incoming Chair Prof. Sigismond Lasocki. The Scientific Committee for this term will be chaired by Prof. Patrick Meybohm, and the Treasurer will be elected by the new Board of Directors. Together, these three roles form the NATA Executive Committee.
The term of office for Board Directors is staggered over several years to ensure continuity and stability in NATA’s governance.
Members whose term of office ends in April 2025 may reapply for a second term.
Elections for the Chair of NATA and Chair of the NATA Scientific Committee took place in April 2024. The past Chair of NATA automatically extends their term by one year on the Board of Directors to ensure continuity.
Why serve?
The NATA Board of Directors is seeking up to six new candidates to serve a three-year term from May 2025 to April 2028. This is a valuable opportunity to contribute to the Society’s strategic direction, influence the future of NATA’s educational content and networking initiatives, and develop leadership skills while serving the PBM, Haemostasis, and Thrombosis community.
The Board of Directors holds full management and administrative authority over NATA. Director roles are voluntary and unpaid. New directors will be elected by the current Board of Directors. Additionally, all Board members automatically become Members of the NATA Scientific Committee.
Board Composition and Selection Criteria
The NATA Board of Directors is committed to achieving a balanced representation of gender and nationality. However, selection will primarily be based on expertise, experience, and potential contributions to the Society. While diversity is an important consideration, the Board’s primary objective is to appoint the most qualified individuals who can support NATA’s mission and drive its continued growth and impact.
Selection Process
The Executive Committee will conduct candidate meetings at NATA25 in Munich on 24 or 25 April 2025.
The Board of Directors will then select individuals who possess the strongest qualifications, experience, and ability to meaningfully contribute to NATA’s mission and objectives.
Eligibility and Application Requirements
Candidate Criteria
- To be eligible, candidates must:
- Be NATA Members in good standing.
- Have a proven track record in their field.
- Have published in PBM, Haemostasis, or Thrombosis.
- Preferably, have experience in officer positions within other international, European, or national PBM, Haemostasis, or Thrombosis societies or relevant societies
- Have an excellent professional network within the PBM, Haemostasis, and Thrombosis community.
Term of Office
May 2025 – April 2028, or until the conclusion of the 2028 NATA Annual Symposium.
Responsibilities and Commitment
Board members are expected to actively contribute to NATA’s development and operations, including but not limited to:
- Identifying topics for NATA monthly webinars.
- Organising and recruiting webinar speakers, as well as contributing as speakers and/or chairs.
- Contributing to the Annual Symposium programme
- Networking on behalf of NATA.
- Promoting NATA and its activities.
- Engaging with the PBM, Haemostasis, and Thrombosis community.
- Fostering relationships with other organisations and stakeholders to expand NATA’s influence.
Commitments
- Candidates must be willing to:
- Serve the full three-year term.
- Attend all Board of Directors meetings (held four times per year, including three virtual meetings and one in-person meeting the day before the Annual Symposium).
- Attend the entire Annual NATA Symposium (a lump sum contribution will be provided towards travel and accommodation).
Application Process
Candidates must submit the following:
- A short CV
- A brief written statement (max. 500 words) outlining their motivation, and experience volunteering for other scientific societies.
- A list of publications.
- A list of conflicts of interest.
Candidates must be nominated by a NATA Member in good standing and be prepared to attend a short interview with the current Executive Committee at the Annual Symposium in Munich on 24 or 25 April 2025.
Application deadline
20 April 2025, 23:59 CET
We look forward to welcoming passionate and dedicated individuals to help shape the future of NATA!
Current Board Of Directors
Term | |||||
Jens Meier | Austria | Chair | 2022-2025 | ||
Sigismond Lasocki | France | Chair Scientific Committee | 2022-2025 | ||
Patrick Meybohm | Germany | Treasurer | 2022-2025 | ||
Elvira Bisbe | Spain | Member | 2022-2025 | ||
Aurora Espinosa | Norway | Member | 2023-2026 | ||
Vernon Louw | South Africa | Member | 2023-2026 | ||
Toby Richards | UK | Member | 2022-2025 | ||
Marie Beatrice Rondinelli | Italy | Member | 2022-2025 | ||
Ravishankar Rao Baikady | UK | Member | 2023-2026 |
April 2025 to April 2026 Board Of Directors
Sigismond Lasocki | France | Chair | 2025-2028 | |
Patrick Meybohm | Germany | Chair Scientific Committee | 2025-2028 | |
Vacant | Treasurer | 2025-2028 | ||
Aurora Espinosa | Norway | Member | 2026 | Term ends in April 2026 |
Vernon Louw | South Africa | Member | 2026 | Term ends in April 2026 |
Jens Meier | Austria | Past President | 2026 | Term ends in April 2026 |
Ravishankar Rao Baikady | UK | Member | 2026 | Term ends in April 2026 |
Elected new member | 2025-2028 | |||
Elected new member | 2025-2028 | |||
Elected new member | 2025-2028 | |||
Elected new member | 2025-2028 | |||
Elected new member | 2025-2028 |